Zydus Cadila on Wednesday reported an increase of 47 per cent in net profit and 22 per cent in income in the first quarter of 2015-16, ended June 30, compared with the same period last fiscal.
While the total operating income was Rs 2,500 crore (Rs 2,050 crore), on a consolidated basis, the net profit was Rs 353 crore (Rs 240 crore), the company said.
The company’s formulations business in the US grew 37 per cent. During the quarter, the Zydus Group had filed six additional ANDAs with the USFDA and launched a new product in the US.
In the Indian formulations market, the company has launched 12 new products, including line extensions, of which four products were the first to be launched in India.
The company’s board has approved the proposal to sub-divide the existing equity shares of face value Rs. 5 each into 5 equity shares of face value Re. 1 each, subject to requisite approvals.